These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18308730)

  • 21. Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors.
    Chung H; Hamza M; Oikonomopoulou K; Gratio V; Saifeddine M; Virca GD; Diamandis EP; Hollenberg MD; Darmoul D
    Biol Chem; 2012 Apr; 393(5):413-20. PubMed ID: 22505523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and Regulation by multiple hormones.
    Korkmaz KS; Korkmaz CG; Pretlow TG; Saatcioglu F
    DNA Cell Biol; 2001 Jul; 20(7):435-45. PubMed ID: 11506707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer.
    Xi Z; Klokk TI; Korkmaz K; Kurys P; Elbi C; Risberg B; Danielsen H; Loda M; Saatcioglu F
    Cancer Res; 2004 Apr; 64(7):2365-70. PubMed ID: 15059887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy.
    Cao B; Yu Q; Zhao W; Tang Z; Cong B; Du J; Lu J; Zhu X; Ni X
    Sci Rep; 2016 Jan; 7():20024. PubMed ID: 26823023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
    Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
    Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancer.
    Black PC; Mize GJ; Karlin P; Greenberg DL; Hawley SJ; True LD; Vessella RL; Takayama TK
    Prostate; 2007 May; 67(7):743-56. PubMed ID: 17373694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).
    Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Blaber M; Blaber SI; Scarisbrick I; Diamandis EP; Hollenberg MD
    Biol Chem; 2006 Jun; 387(6):817-24. PubMed ID: 16800746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.
    Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
    J Cell Mol Med; 2015 Jun; 19(6):1346-56. PubMed ID: 25689283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis.
    Zhang X; Wang W; True LD; Vessella RL; Takayama TK
    Prostate; 2009 May; 69(7):727-36. PubMed ID: 19170048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease activated receptors (PAR)-1 and -2 mediate cellular effects of factor VII activating protease (FSAP).
    Byskov K; Le Gall SM; Thiede B; Camerer E; Kanse SM
    FASEB J; 2020 Jan; 34(1):1079-1090. PubMed ID: 31914657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protease-activated receptor-2 induces expression of vascular endothelial growth factor and cyclooxygenase-2 via the mitogen-activated protein kinase pathway in gastric cancer cells.
    Zhang C; Gao GR; Lv CG; Zhang BL; Zhang ZL; Zhang XF
    Oncol Rep; 2012 Nov; 28(5):1917-23. PubMed ID: 22941376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease-activated receptor-1 in human lung fibroblasts mediates a negative feedback downregulation via prostaglandin E2.
    Sokolova E; Grishina Z; Bühling F; Welte T; Reiser G
    Am J Physiol Lung Cell Mol Physiol; 2005 May; 288(5):L793-802. PubMed ID: 15563688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human airway trypsin-like protease induces amphiregulin release through a mechanism involving protease-activated receptor-2-mediated ERK activation and TNF alpha-converting enzyme activity in airway epithelial cells.
    Chokki M; Eguchi H; Hamamura I; Mitsuhashi H; Kamimura T
    FEBS J; 2005 Dec; 272(24):6387-99. PubMed ID: 16336275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A KLK4 proteinase substrate capture approach to antagonize PAR1.
    Rabinovitch E; Mihara K; Sananes A; Zaretsky M; Heyne M; Shifman J; Aharoni A; Hollenberg MD; Papo N
    Sci Rep; 2021 Aug; 11(1):16170. PubMed ID: 34373558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
    Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
    Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer.
    Kryza T; Bock N; Lovell S; Rockstroh A; Lehman ML; Lesner A; Panchadsaram J; Silva LM; Srinivasan S; Snell CE; Williams ED; Fazli L; Gleave M; Batra J; Nelson C; Tate EW; Harris J; Hooper JD; Clements JA
    Mol Oncol; 2020 Jan; 14(1):105-128. PubMed ID: 31630475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling.
    Wang H; Ubl JJ; Reiser G
    Glia; 2002 Jan; 37(1):53-63. PubMed ID: 11746783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells.
    Ubl JJ; Vöhringer C; Reiser G
    Neuroscience; 1998 Sep; 86(2):597-609. PubMed ID: 9881872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.
    Reid JC; Matsika A; Davies CM; He Y; Broomfield A; Bennett NC; Magdolen V; Srinivasan B; Clements JA; Hooper JD
    Am J Cancer Res; 2017; 7(11):2257-2274. PubMed ID: 29218249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.